Skip to main content
. 2012 Jun 27;12(2):55–62. doi: 10.5230/jgc.2012.12.2.55

Table 2.

Summary of trials for adjuvant therapy

graphic file with name jgc-12-55-i002.jpg

INT = US Intergroup study; MAGIC = Medical Reseach Council Adjuvant Gastric Cancer Infusion Chemotheraphy; ACTS-GC = Adjuvant Chemotherapy Trial of S1 in Gastric Cancer; ECF = epirubicin, cisplatin, 5-FU; GEJ = gastroesophageal junction; DFS = disease free survival; OS = overall survival; RFS = recurrence free survival; PFS = progression free survival; HR = hazard ratio; CI = confidence interval.

HHS Vulnerability Disclosure